Medication Safety Issues
Everolimus may be confused with sirolimus (conventional), sirolimus (protein bound), tacrolimus, temsirolimus
Afinitor may be confused with afatinib
This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.
Tablets (Afinitor, Zortress) and tablets for oral suspension (Afinitor Disperz) are not interchangeable; do not combine formulations to achieve total desired dose.